CNS — Stock Film
STOCK FILMSCENE 1/10CNS · $74.95
Stock Expert AI presents
CNS
Cohen & Steers, Inc
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Cohen & Steers, Inc. What it actually does.

Manages separate client-focused equity portfolios. Manages separate client-focused fixed income portfolios. Now — the numbers.

on the stock market since 2004
424 employees
$3.9B market value
WHERE DOES THE MONEY COME FROM?
58%Open-End Investment Funds
Open-End Investment FundsInstitutional Accounts 24%Closed-End Investment Funds 19%
58% of all revenue comes from a single line: Open-End Investment Funds.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

Revenue last year:
$567.8M
The net profit left over:
$153.2M
Out of every $100 of revenue, $27 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 27%

This is an established company with proven profits.

THE PRICE TAG
MARKET VALUE / ANNUAL PROFIT
25.1×

The market pays 25.1× for every dollar of annual profit — around what a business like this usually costs.

Against companies in its own sector, it looks cheaper than 64% of them.

Analysts' average target sits 17% above today's price.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
99
very strong

Profit power and business quality lead the class.

FINANCIAL STRENGTH
12
very weak

For a bank, strength is measured by capital buffers and reserves — not cash minus debt.

VALUATION
64
average

The price isn’t cheap next to earnings — that’s why this grade sits in the middle.

GROWTH
20
very weak

Clearly below the class average.

PRICE MOMENTUM
66
strong

Clearly above the class average — a step short of the very top.

WORTH WATCHING

Financial Strength: The capital buffer looks thin next to its class; less room to absorb a rough stretch.

Growth: Sales growth trails the sector average.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 30% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/3
A fat but narrowing margin

The net profit margin is 27% — still a thick cushion, though costs have been eating into it lately.

2
THE BRIGHT SIDE · 2/3
Executives are buying their own stock

Over the last 12 months, company executives reported 99 buys and 22 sells. Management buying with its own money is usually read as a good sign.

3
THE BRIGHT SIDE · 3/3
Pays a steady dividend

It pays out $2.63 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/3
Sales are shrinking

Over the last 4 years, sales fell about 1% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.

2
THE RISKS · 2/3
A thin financial cushion

The balance sheet offers little cushion against a rough stretch. Report-card grade: 12/100.

3
THE RISKS · 3/3
Growth trails the sector

The growth engine is running at low revs right now. Report-card grade: 20/100.

FINALE · THE GRADE
B+
67 / 100 · MoonshotScore

On our five-subject report card, CNS sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.

The takeaway: CNS is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s what that quality should cost.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film